154 related articles for article (PubMed ID: 31066482)
1. Neurofibromatosis type 1-related pseudarthrosis: Beyond the pseudarthrosis site.
Brekelmans C; Hollants S; De Groote C; Sohier N; Maréchal M; Geris L; Luyten FP; Ginckels L; Sciot R; de Ravel T; De Smet L; Lammens J; Legius E; Brems H
Hum Mutat; 2019 Oct; 40(10):1760-1767. PubMed ID: 31066482
[TBL] [Abstract][Full Text] [Related]
2. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
3. Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1.
Stevenson DA; Birch PH; Friedman JM; Viskochil DH; Balestrazzi P; Boni S; Buske A; Korf BR; Niimura M; Pivnick EK; Schorry EK; Short MP; Tenconi R; Tonsgard JH; Carey JC
Am J Med Genet; 1999 Jun; 84(5):413-9. PubMed ID: 10360395
[TBL] [Abstract][Full Text] [Related]
4. Case series of congenital pseudarthrosis of the tibia unfulfilling neurofibromatosis type 1 diagnosis: 21% with somatic NF1 haploinsufficiency in the periosteum.
Zheng Y; Zhu G; Liu Y; Zhao W; Yang Y; Luo Z; Fu Y; Mei H; Hu Z
Hum Genet; 2022 Aug; 141(8):1371-1383. PubMed ID: 35024939
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1.
Sant DW; Margraf RL; Stevenson DA; Grossmann AH; Viskochil DH; Hanson H; Everitt MD; Rios JJ; Elefteriou F; Hennessey T; Mao R
J Med Genet; 2015 Apr; 52(4):256-61. PubMed ID: 25612910
[TBL] [Abstract][Full Text] [Related]
6. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
7. Double inactivation of NF1 in tibial pseudarthrosis.
Stevenson DA; Zhou H; Ashrafi S; Messiaen LM; Carey JC; D'Astous JL; Santora SD; Viskochil DH
Am J Hum Genet; 2006 Jul; 79(1):143-8. PubMed ID: 16773574
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients.
Zhu G; Zheng Y; Liu Y; Yan A; Hu Z; Yang Y; Xiang S; Li L; Chen W; Peng Y; Zhong N; Mei H
Orphanet J Rare Dis; 2019 Sep; 14(1):221. PubMed ID: 31533797
[TBL] [Abstract][Full Text] [Related]
9. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K
N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088
[TBL] [Abstract][Full Text] [Related]
10. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
[TBL] [Abstract][Full Text] [Related]
11. NF1 Somatic Mutation in Dystrophic Scoliosis.
Margraf RL; VanSant-Webb C; Mao R; Viskochil DH; Carey J; Hanson H; D'Astous J; Grossmann A; Stevenson DA
J Mol Neurosci; 2019 May; 68(1):11-18. PubMed ID: 30778836
[TBL] [Abstract][Full Text] [Related]
12. Vasculopathy in two cases of NF1-related congenital pseudarthrosis.
Kuorilehto T; Kinnunen P; Nissinen M; Alanne M; Leskelä HV; Lehenkari P; Peltonen J
Pathol Res Pract; 2006; 202(9):687-90. PubMed ID: 16735097
[TBL] [Abstract][Full Text] [Related]
13. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
14. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
[TBL] [Abstract][Full Text] [Related]
15. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
[TBL] [Abstract][Full Text] [Related]
16. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
Rübben A; Bausch B; Nikkels A
Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
[TBL] [Abstract][Full Text] [Related]
17. β-Catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications.
Ghadakzadeh S; Kannu P; Whetstone H; Howard A; Alman BA
FASEB J; 2016 Sep; 30(9):3227-37. PubMed ID: 27306335
[TBL] [Abstract][Full Text] [Related]
18. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.
Paria N; Cho TJ; Choi IH; Kamiya N; Kayembe K; Mao R; Margraf RL; Obermosser G; Oxendine I; Sant DW; Song MH; Stevenson DA; Viskochil DH; Wise CA; Kim HK; Rios JJ
J Bone Miner Res; 2014 Dec; 29(12):2636-42. PubMed ID: 24932921
[TBL] [Abstract][Full Text] [Related]
20. Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium.
Stevenson DA; Little D; Armstrong L; Crawford AH; Eastwood D; Friedman JM; Greggi T; Gutierrez G; Hunter-Schaedle K; Kendler DL; Kolanczyk M; Monsell F; Oetgen M; Richards BS; Schindeler A; Schorry EK; Wilkes D; Viskochil DH; Yang FC; Elefteriou F
J Pediatr Orthop; 2013; 33(3):269-75. PubMed ID: 23482262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
